Search
- Interactive
This interactive tool, updated in January 30, 2024, allows users to explore how various policies to increase the federal minimum wage would affect earnings, employment, family income, and poverty.
- Working Paper
On a present-value basis, CBO estimates that long-term fiscal effects of Medicaid spending on children could offset half or more of the program’s initial outlays, depending on sets of reasonable parameter values.
- Working Paper
This working paper examines how Alabama’s recent expansion of its TANF work requirement to the parents of children between the ages of 6 months and 11 months affects their employment and income.
- Working Paper
This paper examines the effects of physician payment reductions on the use of physicians' services by dual-eligible beneficiaries—people enrolled in both Medicare and Medicaid—over the 1999–2012 period.
- Working Paper
This paper extends a 2019 analysis by Olivier Blanchard by separating total estimated welfare effects of debt into crowding-out and risk-shifting components and estimates the effects of those components under alternative assumptions about technology and preferences.
- Working Paper
This paper introduces a standardized framework to analyze how policy changes alter the distribution of household income to complement CBO’s analyses of policy changes’ budgetary and economic effects.
- Working Paper
This paper examines how the federal budget deficit would have differed in 2018 under four scenarios that vary the distribution of labor earnings while leaving aggregate earnings unchanged.
- Working Paper
CBO developed a new version its health insurance simulation model, HISIM2, including using new sources of input data. This paper describes the new input data and the methods for adjusting and adding to those data to form the sample used in HISIM2.
- Working Paper
Updating its approach to estimating the effects of changes to medical malpractice liability laws on federal spending, CBO explains how and why the modeling is changing and offers a preliminary estimate of the budgetary effects.
- Working Paper
In 2015, brand-name specialty drugs accounted for about 30 percent of net spending on prescription drugs under Medicare Part D and Medicaid, but they accounted for only about 1 percent of all prescriptions dispensed in each program.